Christian Neumann Selected Research

Everolimus

9/2014	The multi-tyrosine kinase inhibitor TKI258, alone or in combination with RAD001, is effective for treatment of human leukemia with BCR-ABL translocation in vitro.
8/2012	The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Neumann Research Topics

Disease

3	Inflammation (Inflammations) 01/2022 - 04/2015
3	Breast Neoplasms (Breast Cancer) 09/2015 - 08/2012
3	Neoplasms (Cancer) 01/2015 - 09/2003
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2019
2	Infections 01/2019 - 08/2014
1	Crohn Disease (Crohn's Disease) 01/2022
1	Autoimmune Pancreatitis 03/2021
1	Immunoglobulin G4-Related Disease 03/2021
1	Pancreatitis 03/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Dysbiosis 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Triple Negative Breast Neoplasms 09/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Leukemia 09/2014
1	Gastroenteritis 01/2009
1	Infarction (Infarctions) 12/2008
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2008
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2008
1	Stroke (Strokes) 12/2008
1	Pathologic Constriction (Stenosis) 11/2003

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 12/2008
2	InterleukinsIBA 01/2022 - 08/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 09/2015 - 12/2004
2	PlatinumIBA 09/2015 - 12/2004
2	CytokinesIBA 01/2015 - 08/2014
2	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2015 - 09/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 09/2014
2	Everolimus FDA Link 09/2014 - 08/2012
2	Carboplatin (JM8)FDA LinkGeneric 08/2012 - 12/2004
2	Glutathione (Reduced Glutathione)IBA 12/2004 - 09/2003
1	Rituximab (Mabthera)FDA Link 03/2021
1	Immunoglobulin G (IgG)IBA 03/2021
1	SteroidsIBA 03/2021
1	Etoposide (VP 16)FDA LinkGeneric 09/2015
1	Ifosfamide FDA LinkGeneric 09/2015
1	Transcription Factors (Transcription Factor)IBA 04/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Conditioned Culture MediaIBA 01/2015
1	ChemokinesIBA 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Pharmaceutical PreparationsIBA 09/2014
1	Imatinib Mesylate (Gleevec)FDA Link 09/2014
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2008
1	Glutamic Acid (Glutamate)FDA Link 12/2008
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 12/2008
1	beta-LactamsIBA 12/2008
1	Nerve Growth Factors (Neurotrophins)IBA 12/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2004
1	DiaminesIBA 12/2004
1	1,2-cyclohexanediamine (dach)IBA 12/2004
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 12/2004
1	Antineoplastic Agents (Antineoplastics)IBA 12/2004
1	NADP (NADPH)IBA 09/2003
1	buthionineIBA 09/2003
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 09/2003

Therapy/Procedure

3	Therapeutics 03/2021 - 01/2009
1	Menstrual Hygiene Products (Menstrual Pad) 01/2020
1	Art Therapy 01/2017
1	Salvage Therapy 09/2015
1	Drug Therapy (Chemotherapy) 09/2015
1	Aftercare (After-Treatment) 01/2015
1	Stents 11/2003